Nordson Other Non-Current Liabilities decreased by 5.7% to $92.29M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.6%, from $77.16M to $92.29M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 11.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.76M | $44.07M | $40.40M | $40.23M | $40.13M | $38.29M | $36.39M | $38.64M | $32.19M | $35.32M | $44.22M | $54.80M | $36.65M | $39.01M | $42.08M | $33.82M | $77.16M | $83.31M | $82.61M | $97.86M | $92.29M |
| QoQ Change | — | -3.7% | -8.3% | -0.4% | -0.3% | -4.6% | -5.0% | +6.2% | -16.7% | +9.7% | +25.2% | +23.9% | -33.1% | +6.5% | +7.9% | -19.6% | +128.1% | +8.0% | -0.8% | +18.5% | -5.7% |
| YoY Change | — | — | — | — | -12.3% | -13.1% | -9.9% | -4.0% | -19.8% | -7.7% | +21.5% | +41.8% | +13.8% | +10.4% | -4.9% | -38.3% | +110.6% | +113.5% | +96.3% | +189.3% | +19.6% |